Oura postpones $2.2B Nasdaq IPO, citing market uncertainty
What's the deal? Oura, the maker of a smart ring that tracks health and sleep, has postponed its planned NasdaqDealroom has a profile for this one. Try Dealroom → listing, citing uncertainty in the IPO market. The company had launched its IPO plans on September 21, aiming to raise up to $2.2 billion through the sale of 50 million shares.
Why now? The delay comes despite "strong demand" and a strengthening of the business since the process began, Oura said Tuesday. Chief executive officer Tom Hale framed the decision as one of timing: "We aim to deliver an extraordinary IPO for our employees and investors and we have the luxury of choosing our moment."
By the numbers: Oura is profitable, with revenue expected to grow 90% year over year for fiscal year 2026. Launched in 2015, its ring has moved beyond sleep tracking into broader health and wellness, increasingly focused on preventative health through AI, analytics, and new features.
What's the endgame? Hale positioned the listing as one milestone rather than a destination. "Our mission is to empower people to live healthier, longer, and an IPO is just one step in our journey," he said. "In the meantime, we will execute against the opportunities ahead."
The signal: Oura is the latest US public market hopeful to pull back, following Holtec NuclearDealroom has a profile for this one. Try Dealroom →, which withdrew its IPO earlier this month over adverse equity market sentiment. The postponement reflects "the challenges facing issuers in an increasingly turbulent market," Samuel Kerr, global head of ECM at MergermarketDealroom has a profile for this one. Try Dealroom →, told CNBCDealroom has a profile for this one. Try Dealroom →, adding that "rising sovereign debt yields are spooking investors" and pushing some to demand wider discounts.
Read more: CNBC
Image credit: Peter Parkes
